S
Shigeo Shimose
Researcher at Kurume University
Publications - 79
Citations - 911
Shigeo Shimose is an academic researcher from Kurume University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 13, co-authored 47 publications receiving 416 citations.
Papers
More filters
Journal ArticleDOI
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis
Hajime Aino,Shuji Sumie,Takashi Niizeki,Ryoko Kuromatsu,Nobuyoshi Tajiri,Masahito Nakano,Manabu Satani,Shingo Yamada,Shusuke Okamura,Shigeo Shimose,Hiroaki Sumie,Takuji Torimura,Michio Sata +12 more
TL;DR: Differences in the clinical characteristics of patients with advanced HCC with extrahepatic metastasis were identified and the Child-Pugh classification, white blood cell count, neutrophil-lymphocyte ratio (NLR) and primary tumor stage were independent predictors of survival for all the patients and for the 81 previously untreated patients.
Journal ArticleDOI
Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study.
Shigeo Shimose,Hideki Iwamoto,Takashi Niizeki,Tomotake Shirono,Yu Noda,Naoki Kamachi,Shusuke Okamura,Masahito Nakano,Hideya Suga,Ryoko Kuromatsu,Taizo Yamaguchi,Takumi Kawaguchi,Masatoshi Tanaka,Kazunori Noguchi,Hironori Koga,Takuji Torimura +15 more
TL;DR: It is concluded that the appearance of hypertension has potential as an early surrogate marker to predict improved prognosis and careful management to avoid discontinuation of treatment leads to longer survival in patients receiving LEN.
Journal ArticleDOI
Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study
Masahito Nakano,Masatoshi Tanaka,Ryoko Kuromatsu,Hiroaki Nagamatsu,Nobuyoshi Tajiri,Manabu Satani,Takashi Niizeki,Hajime Aino,Shusuke Okamura,Hideki Iwamoto,Shigeo Shimose,Tomotake Shirono,Hironori Koga,Takuji Torimura +13 more
TL;DR: The results indicated that sorafenib could be administered for hepatic reserve and as long‐term treatment for advanced HCC patients regardless of their extrahepatic metastasis status.
Journal ArticleDOI
Effects of in‐hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease
Shunji Koya,Takumi Kawaguchi,Ryuki Hashida,Emiko Goto,Hiroo Matsuse,Hiromichi Saito,Keisuke Hirota,Ryoko Taira,Yoshiko Matsushita,Minami Imanaga,Ayu Nagamatsu,Tomotake Shirono,Shigeo Shimose,Hideki Iwamoto,Takashi Niizeki,Ryoko Kuromatsu,Hiroko Miura,Naoto Shiba,Takuji Torimura +18 more
TL;DR: The effects of therapeutic exercise on liver function, 6MWT, and skeletal muscle mass during HCC treatment in patients with CLD are investigated.
Journal ArticleDOI
Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching.
Shigeo Shimose,Masatoshi Tanaka,Hideki Iwamoto,Takashi Niizeki,Tomotake Shirono,Hajime Aino,Yu Noda,Naoki Kamachi,Shusuke Okamura,Masahito Nakano,Ryoko Kuromatsu,Takumi Kawaguchi,Atsushi Kawaguchi,Hironori Koga,Yoshinori Yokokura,Takuji Torimura +15 more
TL;DR: The impact of TACE combined with radiofrequency ablation (TACE+RFA) on the prognosis of HCC patients using decision‐tree analysis after propensity score matching is evaluated.